U.S. Solicitor General Advises Supreme Court to Deny Bayer’s Request in re Roundup Lawsuits

(B.N. Frank) Bayer continues to get an “A” for effort in trying to avoid compensating cancer-stricken Roundup weedkiller users.  Fortunately, past and current efforts aren’t working.  Earlier this year, more sick American Roundup users filed lawsuits against the company.  Thanks to Cary Gillam for continuing to cover Bayer’s attempts to avoid more.

Related Study Links Monsanto’s Roundup to Celiac and Other Autoimmune Diseases; US Government Insists It’s Safe

Source – The activist Post

by B.N. Frank, May 15th, 2022

Another legal blow to Bayer

U.S. Solicitor General tells U.S. Supreme Court it should deny review of Roundup trial loss

The U.S. Solicitor General on Tuesday dealt a blow to Monsanto owner Bayer AG, advising the U.S. Supreme Court that it should deny the company’s request for a review of a key Roundup cancer trial loss.

Bayer has seen the Supreme Court as its last and best hope for putting a stop to the flood of lawsuits filed by tens of thousands of people claiming exposure to Roundup weed killing products caused them to develop non-Hodgkin lymphoma (NHL).

The brief from Solicitor General Elizabeth Prelogar states that “There is no sound reason for the Court to grant review…”

Bayer, which bought Monsanto in 2018, filed its petition to the high court in August, asking the court to review the Ninth Circuit Court of Appeals’ decision that affirmed the district court’s judgment in Monsanto’s 2019 trial loss to plaintiff Edwin Hardeman. The jury in the case agreed with Hardeman’s attorneys that exposure to Monsanto’s glyphosate-based herbicide was a cause of Hardeman’s NHL and that Monsanto failed to warn of the risks despite decades of science showing links between the herbicide and cancer.

Hardeman was awarded approximately $80 million by the jury, but the award was cut by the trial court judge to roughly $25.2 million.

Bayer did pay Hardeman as it awaited word from the U.S. Supreme Court, but accompanied the funds with a letter warning him that he may have to repay the money if the company was successful in getting a reversal by the U.S. Supreme Court.

Bayer maintains Monsanto’s glyphosate herbicides do not cause cancer, and it additionally argues that  the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA), which governs the registration, distribution, sale, and use of pesticides in the United States, preempts “failure-to-warn” claims by Hardeman and other plaintiffs in the Roundup litigation. Because the Environmental Protection Agency (EPA) has approved labels with no cancer warning, failure-to-warn claims should be barred, the company maintains.

In addition to the FIFRA issue, the company urged the Supreme Court to also address whether or not the Ninth Circuit’s standard for admitting expert testimony “is inconsistent” with precedent and federal evidence rules. Bayer argues that the admission of expert testimony in the Hardeman case “departed from federal standards, enabling plaintiff’s causation witnesses to provide unsupported testimony on the principal issue in the case, Roundup’s safety profile.”

The Solicitor General’s brief states that “FIFRA does not preempt respondent’s claims” and found that the evidentiary ruling by the court of appeals was proper.

The Solicitor General wrote that Bayer’s request on the federal rules issue was “particularly misconceived.”

In a statement, lawyers for Hardeman applauded the findings.

“The Solicitor General correctly determined that Mr. Hardeman’s claims are not preempted and told the Supreme Court it should leave the verdict alone,” Hardeman’s legal counsel Aimee Wagstaff and Jennifer Moore said in the statement.

“Despite paying billions of dollars to other Roundup plaintiffs, Monsanto has refused to resolve Mr. Hardeman’s case. Instead, Monsanto has spent the last three years putting the Hardeman family through an unbelievable amount of stress. We are beyond grateful that we are one step closer to giving the Hardemans the resolution they deserve.”

Bayer did not immediately respond to a request for comment.

Read the brief in its entirety here.

Bayer trying to pass the buck to the EPA isn’t the worst idea in the world.  In 2021 the agency was also exposed for possibly being aware for years of a probable link between glyphosate (used in Roundup weedkiller) and non-Hodgkin’s lymphoma.  Of course, the EPA has a long history of not protecting Americans from countless unsafe products including toxic pesticides (see 1, 2) and genetically engineered mosquitoes, billions of which have been and continue to be released in some states (see 1, 2, 3).  WTF EPA?

Stillness in the Storm Editor: Why did we post this?

The news is important to all people because it is where we come to know new things about the world, which leads to the development of more life goals that lead to life wisdom. The news also serves as a social connection tool, as we tend to relate to those who know about and believe the things we do. With the power of an open truth-seeking mind in hand, the individual can grow wise and the collective can prosper.

– Justin

Not sure how to make sense of this? Want to learn how to discern like a pro? Read this essential guide to discernment, analysis of claims, and understanding the truth in a world of deception: 4 Key Steps of Discernment – Advanced Truth-Seeking Tools.

---

Stillness in the Storm Editor’s note: Did you find a spelling error or grammatical mistake? Send an email to corrections@stillnessinthestorm.com, with the error and suggested correction, along with the headline and url. Do you think this article needs an update? Or do you just have some feedback? Send us an email at sitsshow@gmail.com. Thank you for reading.

Source:

hhttps://www.activistpost.com/2022/05/u-s-solicitor-general-advises-supreme-court-to-deny-bayers-request-in-re-roundup-lawsuits.html